+ All Categories
Home > Documents > Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Date post: 22-Feb-2016
Category:
Upload: bowen
View: 47 times
Download: 0 times
Share this document with a friend
Description:
Improving health and protecting human rights  for individuals, communities, and society. Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality. Alisher Latypov , Eurasian Harm Reduction Network, Vilnius Asya Bidordinova , Independent Consultant, Toronto - PowerPoint PPT Presentation
Popular Tags:
12
Improving health and protecting human rights for individuals, communities, and society Alisher Latypov, Eurasian Harm Reduction Network, Vilnius Asya Bidordinova, Independent Consultant, Toronto Avet Khachatrian, Independent Consultant, Toronto Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality Washington D.C., 23 July 2012 XIX International AIDS Conference
Transcript
Page 1: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Improving health and protecting human rights for individuals, communities, and society

Alisher Latypov, Eurasian Harm Reduction Network, VilniusAsya Bidordinova, Independent Consultant, TorontoAvet Khachatrian, Independent Consultant, Toronto

Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 2: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Background and Methodology

Washington D.C., 23 July 2012XIX International AIDS Conference

• 29 countries, 6 sub-regions: The Baltics, Central Europe, South-Eastern Europe, European countries of CIS, South Caucasus and Central Asia

Data collection: Interviews and literature review between August – November 2011

Updated data: Initial findings updated based on UNGASS 2012 country reports, data collected by EHRN for HRI GSHR 2012; feedback from EHRN members and national OST experts

Page 3: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Countries with OST and Year of OST Introduction

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 4: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

OST in Prisons and Authorization of Take-home Dosages

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 5: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Number of Individuals Receiving OST

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 6: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Percentage of People Who Inject Drugs Receiving OST

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 7: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

OST Coverage and Prevalence of HIV among PWID, %

Washington D.C., 23 July 2012XIX International AIDS Conference

Page 8: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Recent OST Assessments in the Region

Washington D.C., 23 July 2012XIX International AIDS Conference

• Subata, Karymbaeva, Moller, WHO Europe, 2011, Penitentiary Institution No. 47 in Bishkek (Kyrgyzstan):“Results of the study indicate the consistent improvement of health and quality of life among opioid substitution therapy patients, as well as the significant reduction of injecting risk behaviour in relation to transmission of HIV and other bloodborne viruses” (p. 2).

• Boltaev, Deryabina, Howard, ICAP, Columbia University, 2012, OST Pilot Program in Kazakhstan:Results include reductions in use of illicit opiates, criminality, HIV risk behavior, and self-assessed improvements in health functioning (p. 5).

Page 9: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Kyrgyz National Funding & The War on Drug Users

• State Drug Control Service: 358,500 USD per year for 962 cases of possession of ≥ 10g• Ministry of Internal Affairs: 474,500 USD per year for 1,800 cases of possession of ≥ 10g• State Service for Correctional Affairs: 402,200 USD per year on inmates sentenced for possession of ≥ 10g

TOTAL direct costs of prosecution of possession of “small” (≥ 10g) amounts of drugs without intent to sell = 1,250,000 USD per year or almost as much as Kyrgyz HIV domestic public spending in 2008XIX International AIDS Conference

Washington D.C., 23 July 2012

Page 10: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

‘Self-induced’ Challenges

1. Political ambivalence, poor financial commitment and strong opposition

2. Containing OST within the remits of narcology

3. Police harassment of OST clients & service providers

4. Keeping OST out of prisons

XIX International AIDS Conference

Washington D.C., 23 July 2012

Page 11: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Increasing Access and Improving Quality

1. National ownership of OST through strong political commitment and sustained national funding

2. Policy reform and adopting supportive legislation

3. Investing in building local capacities for OST advocacy

4. Strengthening human resource capacities and ensuring that patients’ perspective is present

XIX International AIDS Conference

Washington D.C., 23 July 2012

Page 12: Opioid Substitution Therapy in Eurasia: Increasing Access, Improving Quality

Thank you!

XIX International AIDS Conference

Washington D.C., 23 July 2012


Recommended